Theriva Biologics shares are trading lower after the company announced a 1-for-25 reverse stock split.
Portfolio Pulse from Benzinga Newsdesk
Theriva Biologics shares are trading lower after the company announced a 1-for-25 reverse stock split.
August 16, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Theriva Biologics shares are trading lower after the company announced a 1-for-25 reverse stock split.
Reverse stock splits are often perceived negatively by investors as they can indicate underlying financial issues. This perception has led to a drop in Theriva Biologics' share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100